AU5429700A - Method for identifying cell death inhibitory drug and screening method therefor - Google Patents

Method for identifying cell death inhibitory drug and screening method therefor

Info

Publication number
AU5429700A
AU5429700A AU54297/00A AU5429700A AU5429700A AU 5429700 A AU5429700 A AU 5429700A AU 54297/00 A AU54297/00 A AU 54297/00A AU 5429700 A AU5429700 A AU 5429700A AU 5429700 A AU5429700 A AU 5429700A
Authority
AU
Australia
Prior art keywords
cell death
inhibitory drug
identifying cell
death inhibitory
screening method
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU54297/00A
Inventor
Kazunori Imaizumi
Taiichi Katayama
Naoya Sato
Masaya Tohyama
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Tanabe Seiyaku Co Ltd
Original Assignee
Tanabe Seiyaku Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Tanabe Seiyaku Co Ltd filed Critical Tanabe Seiyaku Co Ltd
Publication of AU5429700A publication Critical patent/AU5429700A/en
Abandoned legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G01N33/5076—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics involving cell organelles, e.g. Golgi complex, endoplasmic reticulum
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G01N33/502—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing non-proliferative effects
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G01N33/5044—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics involving specific cell types
    • G01N33/5058—Neurological cells
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2510/00—Detection of programmed cell death, i.e. apoptosis
AU54297/00A 1999-06-25 2000-06-23 Method for identifying cell death inhibitory drug and screening method therefor Abandoned AU5429700A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP11/179277 1999-06-25
JP17927799 1999-06-25
PCT/JP2000/004125 WO2001001132A1 (en) 1999-06-25 2000-06-23 Method for identifying cell death inhibitory drug and screening method therefor

Publications (1)

Publication Number Publication Date
AU5429700A true AU5429700A (en) 2001-01-31

Family

ID=16063037

Family Applications (1)

Application Number Title Priority Date Filing Date
AU54297/00A Abandoned AU5429700A (en) 1999-06-25 2000-06-23 Method for identifying cell death inhibitory drug and screening method therefor

Country Status (2)

Country Link
AU (1) AU5429700A (en)
WO (1) WO2001001132A1 (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2005204218B2 (en) * 1999-08-19 2009-11-26 Immunobiology Limited Vaccine Against Intra-Cellular Pathogens

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN107858378B (en) * 2017-11-20 2020-11-10 中国科学院生物物理研究所 Aging cell model and preparation method thereof

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2005204218B2 (en) * 1999-08-19 2009-11-26 Immunobiology Limited Vaccine Against Intra-Cellular Pathogens

Also Published As

Publication number Publication date
WO2001001132A1 (en) 2001-01-04

Similar Documents

Publication Publication Date Title
AU2879200A (en) System and method for arrhythmia discrimination
AU5324099A (en) Methods for predicting drug response
AU1745201A (en) Method and system for reconnecting dropped calls
AU2003213961A1 (en) Method and apparatus for providing arrhythmia discrimination
AU2999300A (en) System and method for providing standardized individual information
AU5019600A (en) Corn oil and protein extraction method
AU3915400A (en) Methods for monitoring multiple gene expression
AU2416501A (en) Method and system for presenting information
AU2112199A (en) Recombinant cell lines for drug screening
AU7867600A (en) Methods and apparatus for cell analysis
AU3931300A (en) Methods for identifying pathway-specific reporters and target genes, and uses thereof
AU1602801A (en) Oilfield analysis systems and methods
AU2548699A (en) Cell death inhibitors
AU2961400A (en) Automated information filtering and distribution system
AU4827100A (en) Micro-titer plate with filter inserts and related fabrication method
WO2000079450A8 (en) Material management system and method
AU6593600A (en) Drugs inhibiting cell death
AU2308900A (en) Analysis method
AU3178200A (en) Genetic analysis
AU7849200A (en) Mannosidases and methods for using same
AU5285901A (en) System and method for characterizing and identifying agents
AU1553101A (en) Screening method
AU5429700A (en) Method for identifying cell death inhibitory drug and screening method therefor
AU8143898A (en) Methods for identifying drug cores
AU6857500A (en) Screen for axon viability

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase